Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype
about
Chromatin-specific remodeling by HMGB1 and linker histone H1 silences proinflammatory genes during endotoxin toleranceHigh mobility group protein 1: A collaborator in nucleosome dynamics and estrogen-responsive gene expressionSpt2p defines a new transcription-dependent gross chromosomal rearrangement pathway.Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-cateninMelanoma inhibitory activity (MIA): an important molecule in melanoma development and progression.Alarmins: awaiting a clinical responseHigh-mobility group box 1 and cancer.A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.The role of high mobility group box 1 in innate immunity.Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathwayDiagnostic significance of serum HMGB1 in colorectal carcinomasProtumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinomaThe association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.Serum HMGB1 as a prognostic marker for malignant pleural mesotheliomaAssociation of Upregulated HMGB1 and c-IAP2 Proteins With Hepatocellular Carcinoma Development and Progression.The association of HMGB1 gene with the prognosis of HCC.High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.Amphoterin as an extracellular regulator of cell motility: from discovery to disease.Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomasMiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation.Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression.Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis.HMGB1 silence could promote MCF-7 cell apoptosis and inhibit invasion and metastasis.HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersDefective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer.Cardiovascular disease and high-mobility group box 1--is a new inflammatory killer in town?HMGB1 attenuates TGF-β-induced epithelial-mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression.HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarminsHigh mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A.HMGB1 is a promising therapeutic target for acute liver failure.Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells.High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness.Ethyl pyruvate administration inhibits hepatic tumor growth.Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer.Effects of high mobility group protein box 1 and toll like receptor 4 pathway on warts caused by human papillomavirus.Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder.
P2860
Q24319135-193F712B-7260-481E-835D-EB90A8D50278Q26744313-954E2929-4B4B-4335-855B-48F5136E0901Q27938023-076DCBBD-2B73-4096-96F3-280E020CF5F5Q28288573-4434BD22-C5DC-467C-A3BB-4CA99EA57BD1Q30351793-9625E20C-C0F2-4BA3-8704-A131CBB05E70Q30523797-6D453438-3858-4072-A889-03EEF42DED2AQ33638306-E7A04B23-F61C-4E64-AD4D-11FD7E7D98EDQ33798500-92E5F769-2ED4-44C3-B7CB-B6CEFDA37D65Q33941549-C9F217E0-DFF0-45A4-9336-358E91F38D7EQ34227734-B3519BFD-6BE7-4F18-89FC-D7CC12FF39DAQ34230026-5D5028C1-5A1D-4ED8-A1AB-E8E864A0E342Q34334079-1FA3A63F-C324-490C-8AB8-A23175029449Q34428389-A4C107C9-67A7-438C-A430-61D008A75824Q34687224-8DF1D3E6-2441-414C-A313-EC496187447BQ35025037-3F1E7018-C313-40D4-8DAC-73C121FAE0CCQ35106665-8B93403F-0681-427C-BEF9-AA03799E6BADQ35188596-EF3A5B70-0C04-425D-B88C-5E63090A359DQ35661145-2EE29951-37EE-4383-B82D-FD1C0C320E3CQ35761034-92507978-933F-4CE4-B44C-FC5B16CCCBDAQ35981607-4DC11EED-5BFD-462C-8383-8D4D02870F95Q36279625-D0F367AF-01C1-4B59-81E3-5FC15A8FB7E3Q36347619-A5BB0337-2BE3-4973-86FB-CC398AB5FEB4Q36511773-5F5CC127-E7E8-4DB9-BB19-D52A2A6D8513Q36834531-C2B4246C-80BB-40E1-B643-C6AD0F1E22E1Q37229916-EED2EAE0-40A9-4512-B098-161EBE8B7DFAQ37291780-00D54C9B-1D66-4B34-BC7B-56FF9125E453Q37379394-8FEB59B6-6008-4AED-9C1D-96BD28F333ECQ37825897-0993BE45-E7A9-4359-8F62-4B4ABCA784E6Q38040046-C866F1D7-A384-4CF4-9CBF-232DB6582A77Q38712574-D1740BA9-5695-4F0A-A26B-E62819B395C4Q38827721-9DCC8BD5-2FBF-4922-9E10-E15D9622B557Q38939435-97978BF2-44A1-4EDB-8FAD-2178CCEC68E0Q39064881-312B72C3-E350-457F-8355-E478A13A39F9Q39402112-8AD0329A-9AA9-4608-9DBC-82038DE6AD90Q39467052-4DEE829D-59D7-4F81-ABC2-96C99BDB272BQ39771568-EDC1E3CE-2807-446E-974D-AC304A81FF4CQ39827761-B33C7C29-1A4A-4CB0-9712-7E2264E4A9D6Q41976560-640C8B6E-DA6C-4A54-B44F-8528C51B308FQ42037601-F2EF38D3-0D99-4D84-A3D0-B862CE10A44EQ42068869-8F04F398-8EFF-4B0B-BA76-D2CCB6EF0C8D
P2860
Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@ast
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@en
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@nl
type
label
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@ast
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@en
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@nl
prefLabel
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@ast
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@en
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@nl
P2093
P2860
P3181
P1476
Upregulation of HMG1 leads to ...... to their malignancy phenotype
@en
P2093
Michaela Golob
Reinhard Buettner
P2860
P304
P3181
P356
10.1128/MCB.23.8.2991-2998.2003
P407
P577
2003-04-01T00:00:00Z